Xueliang Gao, Ph.D., is an assistant professor in the Department of Pharmacology & Immunology in the College of Medicine at the Medical University of South Carolina (MUSC) and a member of the Cancer Biology & Immunology Research Program at MUSC Hollings Cancer Center. His research advances the understanding of cancer biology with a strong focus on mechanisms that drive tumor progression and therapeutic resistance.
Dr. Gao’s laboratory investigates molecular pathways involved in prostate cancer progression, with particular emphasis on advanced diseases that no longer respond to standard hormone-based therapies. His work aims to identify novel biomarkers and therapeutic targets that can inform more effective and durable treatment strategies. By integrating molecular biology, translational research, and disease focused models, his research supports the development of precision driven approaches to cancer therapy.
He completed his Doctor of Philosophy (Ph.D.) in Cellular and Molecular Biology at Georgia State University and conducted postdoctoral research at the Dana Farber Cancer Institute at Harvard Medical School. Prior to joining MUSC, Dr. Gao served as an instructor in pathology at Harvard Medical School, where he contributed to both research and academic training.
Dr. Gao has authored peer-reviewed publications in leading scientific journals and collaborates with investigators across disciplines to translate fundamental discoveries into clinical impact. His work aligns closely with MUSC’s commitment to advancing cancer research and improving outcomes for patients through innovation and discovery.